Status: Phase 3
Entry Type: Antibody
Molecule Category: UNKNOWN

Indications

Mesh Heading Maximum Phase Reference
Multiple Myeloma; Neoplasms, Plasma Cell Phase 2/Phase 3 ClinicalTrials
CONTENTS